Metro Geriatrics - Medicare Primary Care in Clive, IA

Metro Geriatrics is a medicare enrolled primary clinic (Family Medicine - Geriatric Medicine) in Clive, Iowa. The current practice location for Metro Geriatrics is 13435 University Ave, Suite 500, Clive, Iowa. For appointments, you can reach them via phone at (515) 225-7132. The mailing address for Metro Geriatrics is 500 E Court Ave Ste 305, Des Moines, Iowa and phone number is (515) 237-3974.

Metro Geriatrics is licensed to practice in Iowa (license number 01911). The clinic also participates in the medicare program and its NPI number is 1174933998. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (515) 225-7132.

Contact Information

Metro Geriatrics
13435 University Ave
Suite 500
Clive
IA 50325-8249
(515) 225-7132
(515) 218-1500

Primary Care Clinic Profile

Full NameMetro Geriatrics
SpecialityFamily Medicine
Location13435 University Ave, Clive, Iowa
Authorized Official Name and PositionRobert D. Conner (SOLE MEMBER)
Authorized Official Contact5152257132
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Metro Geriatrics
500 E Court Ave Ste 305
Des Moines
IA 50309-2057

Ph: (515) 237-3974
Metro Geriatrics
13435 University Ave
Suite 500
Clive
IA 50325-8249

Ph: (515) 225-7132

NPI Details:

NPI Number1174933998
Provider Enumeration Date05/01/2014
Last Update Date09/27/2023

Medicare PECOS Information:

Medicare PECOS PAC ID4587887088
Medicare Enrollment IDO20140602002520

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Medical Identifiers

Medical identifiers for Metro Geriatrics such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1174933998NPI-NPPES
IN PROCESSMedicaidIA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207QG0300XFamily Medicine - Geriatric Medicine 01911 (Iowa)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Metro Geriatrics acts as a billing entity for following providers:
Provider NameRobert D Conner
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1447363700
PECOS PAC ID: 2769472224
Enrollment ID: I20040517000130

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameMichael P Oconner
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1396724167
PECOS PAC ID: 2769451830
Enrollment ID: I20040927000722

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameDaniel Miller
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1063437812
PECOS PAC ID: 7012953623
Enrollment ID: I20050706000171

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameRobert L Bender
Provider TypePractitioner - Geriatric Medicine
Provider IdentifiersNPI Number: 1740254218
PECOS PAC ID: 0244262566
Enrollment ID: I20050908000103

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameStephanie L Eason
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1952552655
PECOS PAC ID: 0547457673
Enrollment ID: I20101215000137

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NamePatricia L Russell
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1265748826
PECOS PAC ID: 1658551320
Enrollment ID: I20110211001012

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameJacquelyn E Williams
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1639457534
PECOS PAC ID: 1052583259
Enrollment ID: I20111012000589

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameNicole Fluharty
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1457695595
PECOS PAC ID: 9234383985
Enrollment ID: I20130204000438

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameKatharine Marie Turpin
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1811145691
PECOS PAC ID: 8224195284
Enrollment ID: I20150727000542

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameNicole Dyer
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1619309713
PECOS PAC ID: 5092945733
Enrollment ID: I20160503001572

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameAmanda Lizette Monroy
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1073068979
PECOS PAC ID: 9537457650
Enrollment ID: I20161005001597

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameTaylor M Sula
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1518445766
PECOS PAC ID: 3274883319
Enrollment ID: I20180911000969

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameSarah Sue Neal
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1124580329
PECOS PAC ID: 9032452578
Enrollment ID: I20190523002376

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameNadia Ann Clark
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1376106302
PECOS PAC ID: 5991030298
Enrollment ID: I20190709001765

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameJulianne Carson-hem
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1184211591
PECOS PAC ID: 7315101094
Enrollment ID: I20210108000798

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameMarina Pathan
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1598334781
PECOS PAC ID: 9335543685
Enrollment ID: I20210809001111

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

Provider NameKelsee Browning
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1669885745
PECOS PAC ID: 8820394265
Enrollment ID: I20230106001968

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more Medical News

› Verified 5 days ago

News Archive

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.

White House announces $600 million for community health centers, medical records

The White House announced Wednesday it would spend $600 million to build and enhance community health centers and medical records.

Study finds rise in multi-drug resistant infections among U.S. children

Antibiotic-resistant Acinetobacter baumannii infections, one of the most common hospital-acquired infections in children across the United States, are on the rise, according to results of a recent study published in the Journal of the Pediatric Infectious Diseases Society on March 22.

CD22 protein could prove to be important new target for anti-cancer therapy

A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed that specific targeting of the protein with monoclonal antibodies reduced the size of tumors, lowered the occurrence of metastases and substantially lengthened survival time.

Read more News

› Verified 5 days ago


Family Medicine in Clive, IA

Digestive And Liver Disease Consultants, P.c.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1601 Nw 114th St, Ste 342, Clive, IA 50325
Phone: 515-223-4823    Fax: 515-223-0482
Pure Wellness Chiropractic & Acupuncture
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 1250 Nw 128th St, 120, Clive, IA 50325
Phone: 515-225-2220    Fax: 515-225-2229
Mercyone Bone Density Testing
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1601 Nw 114th St, Clive, IA 50325
Phone: 515-222-7000    Fax: 515-222-7037
Mercy West Internal Medicine
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1601 Nw 114th St, Suite 240, Clive, IA 50325
Phone: 515-222-7700    Fax: 515-222-7138
New Leaf Wellness
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 12129 University Ave Ste 1500, Clive, IA 50325
Phone: 515-657-6210    Fax: 515-657-6208
Iowa Digestive Disease Center
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 1378 Nw 124th Street, Suite 200, Clive, IA 50325
Phone: 515-288-6097    Fax: 515-288-8335

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.